BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Elan Pharmaceuticals (South San Francisco, CA) 

800 Gateway Boulevard

South San Francisco  California  94080  U.S.A.
Phone: 650-877-7647 Fax: 650-877-7669


SEARCH JOBS

View Clinical Trials from BioPharm Insight

Elan Corporation, plc is a neuroscience-based biotechnology company that is focused on discovering, developing, manufacturing and marketing advanced therapies in neurology, autoimmune diseases and severe pain.

Click here to visit the Career section!
http://www.elan.com/careers/


 Key Statistics


Email:
Ownership: Public

Web Site: Elan Pharmaceuticals
Employees:
Symbol: ELN
 



Industry
Biotechnology






 Company News
Elan Pharmaceuticals (ELN) Reports Second Quarter and First Half 2013 Financial Results 7/24/2013 6:35:25 AM    More...
Elan Pharmaceuticals (ELN) Lab Liquidation Auctions -- South San Francisco Closure; to be Hosted by BioSurplus on Its Secure Online Auction Platform 1/9/2013 9:42:25 AM    More...
Elan Pharmaceuticals (ELN) Hoping Alzheimer's Drug Will "Transform" Firm 5/25/2012 7:55:40 AM    More...
Elan Pharmaceuticals (ELN) to Present at the Leerink Swann 2012 Global Healthcare Conference 2/2/2012 6:19:42 AM    More...
Intellect Neurosciences, Inc. Files Appeal in Europe in Response to Opposition Proceedings Instituted by Elan Pharmaceuticals (ELN) and Wyeth (WYE)/Pfizer Inc. (PFE) 12/15/2011 10:55:05 AM    More...
Elan Pharmaceuticals (ELN) Presents 7th Annual Danville Concours d'Elegance Weekend 8/30/2011 5:50:01 AM    More...
Elan Pharmaceuticals (ELN) Pays Transition Therapeutics Inc. (TTH.TO) $9M in Amended Deal for Phase II Alzheimer Candidate; Transition Eligible for $11 Million More 12/27/2010 7:40:40 AM    More...
Lundbeck Inc. (formerly Ovation Pharmaceuticals) CFO: Elan Pharmaceuticals (ELN) Not an Acquisition Option Now 5/13/2009 11:26:23 AM    More...
Elan Corporation PLC (ELN)'s Tysabri May Reverse MS Damage, Shares Up 4/29/2009 7:28:54 AM    More...
Intellect Neurosciences, Inc. Grants to Top Tier Global Pharmaceutical Company an Option to License Certain Alzheimer's Patents and Patent Applications 10/8/2008 8:57:49 PM    More...
1234